Basic Information
Daypro
0025-1381
Regulatory Information
0025-1381
NDA018841
C73594
November 17, 2022
USA
These highlights do not include all the information needed to use DAYPRO safely and effectively. See full prescribing information for DAYPRO. DAYPRO (oxaprozin) caplets, for oral useInitial U.S. Approval: 1992
HUMAN PRESCRIPTION DRUG LABEL
20
Company Information
Pfizer Laboratories Div Pfizer Inc
134489525
Active Ingredients
MICROCRYSTALLINE CELLULOSE
Code: OP1R32D61U
Class Code: IACT
METHYLCELLULOSE (100 MPA.S)
Code: 4GFU244C4J
Class Code: IACT
MAGNESIUM STEARATE
Code: 70097M6I30
Class Code: IACT
HYPROMELLOSE, UNSPECIFIED
Code: 3NXW29V3WO
Class Code: IACT
POLACRILIN POTASSIUM
Code: 0BZ5A00FQU
Class Code: IACT
POLYETHYLENE GLYCOL, UNSPECIFIED
Code: 3WJQ0SDW1A
Class Code: IACT
TITANIUM DIOXIDE
Code: 15FIX9V2JP
Class Code: IACT
Active Moieties
OXAPROZIN
Code: MHJ80W9LRB